BLU-945

• Description:

  BLU-945 is a reversible, potent, highly selective, and orally available epidermal growth factor receptor tyrosine kinase inhibitor (TKIs) . BLU-945 inhibits EGFR phosphorylation in EGFR L858R/T790M/C797S and EGFR ex19del/T790M/C797S mutant cell lines. BLU-945 can be used in lung cancer research, including non-small cell lung cancer (NSCLC) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  556.7

• Molecular Formula:

  C28H37FN6O3S

• Notes:

  Research use only, not for human use.

• Receptor:

  EGFR

• CAS Number:

  2660250-10-0